We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Hepatitis C FREE

John L. Zeller, MD, PhD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2007;297(7):768. doi:10.1001/jama.297.7.768.
Text Size: A A A
Published online

Hepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV). In the United States, 25 000 to 30 000 new infections occur each year. It is a slowly progressive liver disease, usually without symptoms, that may take 20 to 30 years to cause serious liver damage. About three quarters of persons infected with this virus develop chronic (long-term) hepatitis (inflammation of the liver). An estimated 2.7 million to 3.4 million Americans are chronically infected and 12 000 deaths per year are attributed to the medical complications related to hepatitis C. HCV has become the major cause of liver disease leading to cirrhosis (scarring of the liver) and liver cancer and is now the most frequent indication for liver transplantation.

There are 6 major types (strains) of hepatitis C, referred to as genotypes (based on DNA sequences). The most common genotype in the United States is genotype 1. In 1992, a blood test was discovered and implemented to identify individuals exposed to HCV and to screen blood donors. Knowing the genotype of the virus can have important consequences regarding care. The February 21, 2007, issue of JAMA includes an article about various tests for the diagnosis of HCV infection. These tests provide critical information for guiding treatment and measuring the response to therapy.


HCV is spread primarily by direct contact with the blood of an HCV-infected person. It is not spread by sneezing, hugging or kissing, coughing, breastfeeding, food or water, or other casual contact. There is no vaccine to prevent the infection or spread of HCV.


Most individuals who are newly infected or chronically infected with HCV do not have symptoms. If present, the symptoms may be very mild, nonspecific, and intermittent. They may be flu-like, including fatigue, poor appetite, nausea, muscle and joint pain, or a mild discomfort in the area of the liver.


  • Ever injected illegal drugs

  • Received clotting factors made before 1987

  • Received blood or organ transplants before July 1992

  • Ever were treated with hemodialysis

  • Have liver disease of uncertain cause

  • Have a needlestick with HCV-positive blood

  • Are 12 to 18 months of age and born to a mother who is HCV-positive


  • Selection of patients for treatment is guided by virus testing (NAT-nucleic acid tests), liver function tests (blood tests), imaging studies (CT scan, MRI, or ultrasound), and liver biopsy.

  • Peginterferon combined with ribavirin are the 2 antiviral drugs now being used.

  • Side effects of drug treatment can be serious, and your doctor may suggest that mild cases of hepatitis C infection should be watched carefully instead of treated with drugs.

  • Periodic blood tests are required to monitor the infection.

  • Treatment includes eating a well-balanced diet, drinking plenty of fluids, avoiding alcohol, and exercising.

  • For end-stage liver disease, liver transplantation may be the only treatment option.



To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on hepatitis A was published in the July 13, 2005, issue; and one on hepatitis B was published in the November 10, 1999, issue.

Sources: American Liver Foundation, American Academy of Family Physicians, Hepatitis Foundation International

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Spanish Patient Pages
Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
The end of the hepatitis C burden: Really? Hepatology Published online Aug 3, 2016;